4,296
Views
12
CrossRef citations to date
0
Altmetric
Articles

High-intensity focused ultrasound treatment for symptomatic uterine fibroids: a systematic review and meta-analysis

, , &
Pages 230-238 | Received 30 Sep 2021, Accepted 10 Jan 2022, Published online: 30 Jan 2022

References

  • Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589–1592.
  • Wu F, Wang ZB, Chen WZ, et al. Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol. 2004;30(2):245–260.
  • Jenne JW, Preusser T, Gunther M. High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. Z Med Phys. 2012; 22(4):311–322.
  • Ringold S. FDA approves ultrasound fibroid therapy. JAMA. 2004;292(23):2826.
  • Lyon PC, Rai V, Price N, et al. Ultrasound-guided high intensity focused ultrasound ablation for symptomatic uterine fibroids: preliminary clinical experience. Ultraschall Med. 2020;41(05):550–556.
  • Marinova M, Ghaei S, Recker F, et al. Efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) for uterine fibroids: an observational single-center study. Int J Hyperthermia. 2021;38(2):30–38.
  • Kamp JEK, David M, ScheurigMuenkler C, et al. Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids. Rofo. 2013;185(2):136–143.
  • Dobrotwir A, Pun E. Clinical 24 month experience of the first MRgFUS unit for treatment of uterine fibroids in Australia. J Med Imaging Radiat Oncol. 2012; 56(4):409–416.
  • Zhang L, Wang ZB. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010;4(3):294–302.
  • Łoziński T, Filipowska J, Gurynowicz G, et al. The effect of high-intensity focused ultrasound guided by magnetic resonance therapy on obstetrical outcomes in patients with uterine fibroids - experiences from the main Polish center and a review of current data. Int J Hyperthermia. 2019;36(1):582–590.
  • Zou M, Chen L, Wu C, et al. Pregnancy outcomes in patients with uterine fibroids treated with ultrasound-guided high intensity focused ultrasound. BJOG. 2017;124(S3):30–35.
  • Sandberg EM, Tummers FHMP, Cohen SL, et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and Meta-analysis. Fertil Steril. 2018;109(4):698–707.
  • Taran FA, Tempany CM, Regan L, et al. Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol. 2009;34(5):572–578.
  • Froeling V, Meckelburg K, Schreiter NF, et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results. Eur J Radiol. 2013;82(12):2265–2269.
  • Froeling V, Meckelburg K, Scheurig-Muenkler C, et al. Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids. Cardiovasc Intervent Radiol. 2013;36(6):1508–1513.
  • Wang X, Qin J, Wang L, et al. Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy. Arch Gynecol Obstet. 2013;288(4):851–858.
  • Wang X, Qin J, Chen J, et al. The effect of high-intensity focused ultrasound treatment on immune function in patients with uterine fibroids. Int J Hyperthermia. 2013;29(3):225–233.
  • Wang F, Tang L, Wang L, et al. Ultrasound-guided high-intensity focused ultrasound vs. laparoscopic myomectomy for symptomatic uterine myomas. J Minim Invasive Gynecol. 2014;21(2):279–284.
  • Barnard EPD, AbdElmagied Ahmed MM, Vaughan Lisa EMS, et al. Periprocedural outcomes comparing fibroid embolization and focused ultrasound: a randomized controlled trial and comprehensive cohort analysis. Am J Obstet Gynecol. 2017;216(5):500e1–500e11.
  • Liu Y, Ran W, Shen Y, et al. High-intensity focused ultrasound and laparoscopic myomectomy in the treatment of uterine fibroids: a comparative study. BJOG. 2017;124(3):36–39.
  • Mohr-Sasson Aya, Machtinger Ronit, Mashiach Roy, et al. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors. Am J Obstet Gynecol. 2018;219(4):375e1–375e7.
  • Laughlin-Tommaso Shannon, Barnard Emily PD, AbdElmagied Ahmed M, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019;220(2):174e1–174e13.
  • Cui Y, Dong Y, Guo B, et al. Effect of HIFU on endometrial receptivity and sex hormone level in uterine fibroid patients and analysis of influencing factors for its treatment rate. Exp Ther Med. 2019;17(3):2291–2297.
  • Wang Y, Liu X, Wang W, et al. Long-term clinical outcomes of US-Guided High-Intensity focused ultrasound ablation for symptomatic submucosal fibroids: a retrospective comparison with Uterus-Sparing surgery. Acad Radiol. 2021; 28(8):1102–1107.
  • Hu L, Zhao JS, Xing C, et al. Comparison of focused ultrasound surgery and hysteroscopic resection for treatment of submucosal uterine fibroids (FIGO type 2). Ultrasound Med Biol. 2020;46(7):1677–1685.
  • Wu G, Li R, He M, et al. A comparison of the pregnancy outcomes between ultrasound-guided high-intensity focused ultrasound ablation and laparoscopic myomectomy for uterine fibroids: a comparative study. Int J Hyperthermia. 2020; 37(1):617–623.
  • Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG. 2018;125(3):354–364.
  • Yu SCH, Cheung ECW, Leung VYF, et al. Oxytocin-Augmented and Non-Sedating High-Intensity-Focused ultrasound (HIFU) for uterine fibroids showed promising outcome as compared to HIFU alone or uterine artery embolization. Ultrasound Med Biol. 2019;45(12):3207–3213.
  • Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020;127(11):1422–1428.
  • Jiang Z, Li Q, Li W, et al. A comparative analysis of pregnancy outcomes of patients with uterine fibroids after high intensity focused ultrasound ablation and laparoscopic myomectomy: a retrospective study. Int J Hyperthermia. 2021;38(1):79–84.
  • Borah BJ, Yao X, Laughlin-Tommaso SK, et al. Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database. Obstet Gynecol. 2017;130(5):1047–1056.
  • AbdElmagied AM, Vaughan LE, Weaver AL, et al. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial. Am J Obstet Gynecol. 2016; 215(3):338.e1–338.e18.
  • Qu K, Mao S, Li J, et al. The impact of ultrasound-guided high-intensity focused ultrasound for uterine fibroids on ovarian reserve. Int J Hyperthermia. 2020; 37(1):399–1403.
  • Ciebiera M, Łoziński T. The role of magnetic resonance-guided focused ultrasound in fertility-sparing treatment of uterine fibroids-current perspectives. Ecancermedicalscience. 2020;14:1034.
  • Ravina JH, Merland JJ, Herbreteau D, et al. Preoperative embolization of uterine fibroma. preliminary results (10 cases). Presse Med. 1994;23(33):1540.
  • Gabriel-Cox K, Jacobson GF, Armstrong MA, et al. Predictors of hysterectomy after uterine artery embolization for leiomyoma. Am J Obstet Gynecol. 2007;196(6):e1–6.
  • Schirf BE, Vogelzang RL, Chrisman HB. editors. Complications of uterine fibroid embolization. Seminars in interventional radiology. New York (NY): Thieme Medical Publishers; 2006. p. 333.
  • Kim CW, Shim HS, Jang H, Song YG. The effects of uterine artery embolization on ovarian reserve. Eur J Obstet Gynecol Reprod Biol. 2016;206:172–176.
  • Arthur R, Kachura J, Liu G, et al. Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve. J Obstet Gynaecol Can. 2014;36(3):240–247.
  • Mara M, Maskova J, Fucikova Z, et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31(1):73–85.
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin no.96: alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112:387–400.
  • Dariushnia SR, Nikolic B, Stokes LS, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol. 2014;25(11):1737–1747.
  • Ghanaati H, Sanaati M, Shakiba M, et al. Pregnancy and its outcomes in patients after uterine fibroid embolization: a systematic review and Meta-Analysis. Cardiovasc Intervent Radiol. 2020;43(8):1122–1133.
  • Liu L, Wang T, Lei B. Uterine artery embolization compared with high-intensity focused ultrasound ablation for the treatment of symptomatic uterine myomas: a systematic review and Meta-analysis. J Minim Invasive Gynecol. 2021;28(2):218–227.